全文获取类型
收费全文 | 3618篇 |
免费 | 686篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 65篇 |
妇产科学 | 51篇 |
基础医学 | 201篇 |
口腔科学 | 170篇 |
临床医学 | 1120篇 |
内科学 | 405篇 |
皮肤病学 | 39篇 |
神经病学 | 179篇 |
特种医学 | 96篇 |
外国民族医学 | 1篇 |
外科学 | 324篇 |
综合类 | 369篇 |
一般理论 | 1篇 |
预防医学 | 551篇 |
眼科学 | 28篇 |
药学 | 277篇 |
3篇 | |
中国医学 | 313篇 |
肿瘤学 | 108篇 |
出版年
2024年 | 8篇 |
2023年 | 166篇 |
2022年 | 135篇 |
2021年 | 206篇 |
2020年 | 229篇 |
2019年 | 301篇 |
2018年 | 244篇 |
2017年 | 217篇 |
2016年 | 207篇 |
2015年 | 193篇 |
2014年 | 286篇 |
2013年 | 372篇 |
2012年 | 212篇 |
2011年 | 303篇 |
2010年 | 229篇 |
2009年 | 143篇 |
2008年 | 172篇 |
2007年 | 129篇 |
2006年 | 123篇 |
2005年 | 107篇 |
2004年 | 79篇 |
2003年 | 94篇 |
2002年 | 46篇 |
2001年 | 51篇 |
2000年 | 33篇 |
1999年 | 21篇 |
1998年 | 7篇 |
1997年 | 12篇 |
1996年 | 5篇 |
1995年 | 3篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有4356条查询结果,搜索用时 15 毫秒
1.
《Value in health》2022,25(12):1958-1966
ObjectivesNational health technology assessments (HTAs) across Europe show differences in evidentiary requirements from assessments by the European Medicines Agency (EMA), affecting time to patient access for drugs after marketing authorization. This article analyzes the differences between EMA and HTA bodies’ evidentiary requirements for oncology drugs and provides recommendations on potential further alignment to minimize and optimally manage the remaining differences.MethodsInterviews were performed with representatives and drug assessment experts from EMA and HTA bodies to identify evidentiary requirements for several subdomains and collect recommendations for potentially more efficiently addressing differences. A comparative analysis of acceptability of the evidence by EMA and the HTA bodies and for potential further alignment between both authorities was conducted.ResultsAcceptability of available evidence was higher for EMA than HTA bodies. HTA bodies and EMA were aligned on evidentiary requirements in most cases. The subdomains showing notable differences concerned the acceptance of limitation of the target population and extrapolation of target populations, progression-free survival and (other) surrogate endpoints as outcomes, cross-over designs, short trial duration, and clinical relevance of the effect size. Recommendations for reducing or optimally managing differences included joint early dialogues, joint relative effectiveness assessments, and the use of managed entry agreements.ConclusionsDifferences between assessments of EMA and HTA bodies were identified in important areas of evidentiary requirements. Increased alignment between EMA and HTA bodies is suggested and recommendations for realization are discussed. 相似文献
2.
3.
Samir Gupta MD MSCS Gloria D. Coronado PhD Keith Argenbright MD Alison T. Brenner PhD MPH Sheila F. Castañeda PhD Jason A. Dominitz MD MHS Beverly Green MD MPH Rachel B. Issaka MD MAS Theodore R. Levin MD Daniel S. Reuland MD MPH Lisa C. Richardson MD MPH Douglas J. Robertson MD MPH Amit G. Singal MD MS Michael Pignone MD MPH 《CA: a cancer journal for clinicians》2020,70(4):283-298
Uptake of colorectal cancer screening remains suboptimal. Mailed fecal immunochemical testing (FIT) offers promise for increasing screening rates, but optimal strategies for implementation have not been well synthesized. In June 2019, the Centers for Disease Control and Prevention convened a meeting of subject matter experts and stakeholders to answer key questions regarding mailed FIT implementation in the United States. Points of agreement included: 1) primers, such as texts, telephone calls, and printed mailings before mailed FIT, appear to contribute to effectiveness; 2) invitation letters should be brief and easy to read, and the signatory should be tailored based on setting; 3) instructions for FIT completion should be simple and address challenges that may lead to failed laboratory processing, such as notation of collection date; 4) reminders delivered to initial noncompleters should be used to increase the FIT return rate; 5) data infrastructure should identify eligible patients and track each step in the outreach process, from primer delivery through abnormal FIT follow-up; 6) protocols and procedures such as navigation should be in place to promote colonoscopy after abnormal FIT; 7) a high-quality, 1-sample FIT should be used; 8) sustainability requires a program champion and organizational support for the work, including sufficient funding and external policies (such as quality reporting requirements) to drive commitment to program investment; and 9) the cost effectiveness of mailed FIT has been established. Participants concluded that mailed FIT is an effective and efficient strategy with great potential for increasing colorectal cancer screening in diverse health care settings if more widely implemented. 相似文献
4.
证据分级和推荐体系在中医药循证医学发展中不可或缺。中医药理论及临床独具特色,照搬西方医学分级体系不合实际,国内众多学者对中医药领域证据分级和推荐体系进行了多年的探索。本文回顾国际临床证据和推荐体系的发展,总结分析目前国内较有代表性的中医药证据分级体系,阐述中医证据特点及发展趋势,为中医临床证据分级体系的成熟与完善提供参考,进而推动中医证据评价的研究。 相似文献
5.
Bartosz Slomka Witold Rongies Janusz Sierdzinski Wlodzimierz Dolecki Marta Worwag Ewa Trzepla 《Acta orthopaedica et traumatologica turcica》2019,53(1)
Objective
The aim of the study was to assessment the impact of hip osteoarthritis on postural stability.Methods
One hundred and twenty-five randomly selected women 20–85 years old (mean age of 49 ± 24.4 years) were assigned to three groups based on age, health status and activity level. Group 1 (cases) – elderly women with diagnosed hip osteoarthritis, group 2 (control) - women without hip osteoarthritis, and group 3 (control) - healthy young women. Assessment of postural stability were measured using a WIN-POD Pel 38 electronic podometer. Statistica 10 software was used to perform t-test resulting in significance level of p < 0.05.Results
Significant differences in pedobarographic balance measurements were observed between the study groups with eyes opened or closed (deviation length eyes open: group 1–3 and 2–3 p < 0.0001; eyes closed group 1–2 p = 0.19; 1–3 and 2–3 p < 0.0001; deviation area eyes open: group 1-3 and 2–3 p < 0.0001; eyes closed group 1–3 and 2–3 p < 0.0001; deviation velocity eyes open: group1-3 and 2–3 p < 0.0001; eyes closed group 1–2 p < 0.010, 1–3 and 2–3 p < 0.0001). The poorest postural stability was observed in patients with hip osteoarthritis (deviation length eyes open vs eyes closed 180.8/201.7 p = 0.028, deviation area 128.7/145.7 p = 0.771, deviation velocity 5.1/6.1 p < 0.0001), and the best postural stability was observed in young women (deviation length 111.3/137.5 p < 0.0001, deviation area 57/76.9 p = 0.003, deviation velocity 3.4/4.2 p < 0.0001).Conclusion
(1) Osteoarthritic degeneration of the hip joint results in a significant disturbance in proprioception. This finding was reflected by the inferior stability parameters collected from subjects with hip osteoarthritis when asked to stand with their eyes closed. These finding were not observed in the other groups. (2) The disorder of the body stability of people with osteoarthritis may be a relative indication for the implantation of hip arthroplasty. 相似文献6.
Matheus Frana Perazzo Ana Luisa Caldas Otoni Matheus Silva Costa Ana Flvia Granville‐Granville Saul Martins Paiva Paulo Antnio Martins‐Júnior 《International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children》2019,29(6):692-711
7.
《Vaccine》2022,40(6):924-933
The European Clinical Trial Regulation No 536/2014 is the first mandate for a non-technical, publicly disclosed, plain language summary (PLS) of clinical trial results. This easy-to-understand summary has the potential to inform the public about clinical trial results and thereby improve health literacy in vaccines.To investigate the utility of the PLS, we undertook 2 online surveys (July/October 2020) in the United Kingdom, the United States and India. Participants were selected by quota sampling to ensure representation of gender, age and parental status. Those lacking interest in vaccine clinical research were excluded. In survey 1, participants were questioned about their interest in and expectations of vaccine trial results. In survey 2, the perceptions of participants to a range of written communication styles used in publicly available PLSs were evaluated.A total of 66 (13%) and 122 (29%) individuals were excluded solely due to lack of interest in vaccine clinical research in surveys 1 and 2, respectively; 450 respondents (150/country) completed survey 1 and 300 (100/country) completed survey 2. In survey 1, there was a correlation (p < 0.01) between claimed knowledge of and trust in vaccines. Healthcare professionals were the most trusted source for vaccine information, while vaccine companies were ranked relatively low. In survey 2, infographic PLS formats were considered easiest to understand, most engaging and the strongest communicators. Emphasizing the main points of the infographics in the text did not improve comprehension or recall. Most respondents (86%) indicated that they would like to see this type of communication in the future.Overall, this research suggests that the PLS, by optimizing content and format, has a potential to increase health literacy, and thereby, as part of a wider integrated communication strategy, build vaccine knowledge and confidence. 相似文献
8.
9.
10.
目的 根据上臂围选用合适尺寸袖带测量血压的最佳证据进行总结,为临床提供理论参考。方法 根据循证护理的方法确立问题,利用计算机按“6S”证据模型,检索有关血压测量袖带尺寸的选择,包括指南、专家共识、临床决策和证据总结,由4名完成循证护理培训的研究员对纳入的文献独立评价,并对选取出符合质量标准的文献进行证据提取。结果 该研究纳入证据7篇,其中临床实践指南4篇、专家共识2篇、系统评价1篇,对相关证据进行汇总,总结了3方面内容。结论 应加强对医护人员血压测量规范流程的培训,根据患者的上臂围选用尺寸适合的袖带进行血压测量,减少因袖带不当带来的测量误差以减少高血压误诊和漏诊。 相似文献